The portal uses cookies to provide service functions such as “Bookmark” and to improve website usage. Information and opt-out options can be found in the cookie settings in the privacy policy.

Search

8-530.b1:

Nuclear medicine therapy: Therapy with unsealed radionuclides: Intracavity radiotherapy with unsealed radionuclides: Intracavity radionuclide therapy with radioactive antibodies

A radioactive drug that was linked to an antibody was placed in a cavity in your body.

There are several cavities in the body where various organs are located. For example, the chest is where the lungs and the heart are located, and the abdominal cavity is where the abdominal are located.

Antibodies are defense substances that are found in the body. However, antibodies can also be synthetically manufactured to treat certain illnesses. Antibodies recognize proteins on the surface of cells and bind to them. A certain antibody only ever binds to matching proteins. Depending on type, task and origin, the cells of the body have typical proteins on their surface.

The radioactive drug accumulates where the antibody binds to the relevant protein. This is where the radiation emitted by the radioactive drug has its effect. The intention is for the radiation to damage pathologically altered cells in the body.

Additional indicator

If necessary, additional letters are appended to OPS codes to indicate which side of the body is affected.

  • L: Left
  • R: Right
  • B: Both sides

Further information

Note

Your doctor will assist you with any health-related questions and explain the OPS code to you in a direct consultation if necessary.

Source

Provided by the non-profit organization “Was hab’ ich?” gemeinnützige GmbH on behalf of the Federal Ministry of Health (BMG).